Abstract: A light fixture delivering electrically controlled lighting distributions for mounting within an installed panel system typically used in ceiling and wall constructions and incorporating acoustic, drywall or wood panels. The light fixture can provide low-glare or wide spread “batwing” ambient light or more directional wall wash, task and accent lighting. The light fixture comprises one or more LED boards and an optical element which can be back-lit or edge-lit. The light fixture body is configurable, comprising a 3-dimensional extruded elongate body with its ends cut at a configured angle. The body typically comprises additional side support features that support and enclose the edge of installed panels. In the case of a T-bar based ceiling grid system the side support features may also replicate the function and appearance of T-bar horizontal and vertical portions. The body comprises features to retain and align LED boards, reflectors and a back-lit or edge-lit optical element.

Abstract: A lighting assembly includes at least one light source array provided in a housing and a light scattering primary transmissive optical element having at least one focal region positioned substantially parallel or concentric with the light source array. Lens features of the optical element may include a Fresnel lens pattern to produce at least one focal region. An auxiliary transmissive optical element may be provided to further control light distribution and brightness uniformity.

Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.

Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.

Abstract: A system such as a database management system determines a rule to impose sorted order upon a column without applying a sorting algorithm to the column and stores the rule to be applied to sort the column. In an embodiment, a permutation is the rule. The column, in an embodiment, is a column of a database table. In some cases, the rule is used to efficiently impose a correct sorted order on a subset of unsorted columns without the use of a sorting algorithm. In some cases, the rule is generated based at least in part on another column that is sorted using a sorting algorithm such as quicksort.

Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.

Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.

Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.

Abstract: The present invention provides methods for the prevention or treatment of Parkinson's Disease using Abelson-family tyrosine kinase inhibitors.

Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.

Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.

Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.

Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.

Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.

Abstract: The present invention relates to novel compounds which are capable of inhibiting the interaction of LFA-1 with its counter ligands.

Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.

Abstract: The present invention relates to novel compounds which are capable of inhibiting the interaction of LFA-1 with its counter ligands.

Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.

Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.